232 related articles for article (PubMed ID: 27742636)
1. Drug Concentration Thresholds Predictive of Therapy Failure and Death in Children With Tuberculosis: Bread Crumb Trails in Random Forests.
Swaminathan S; Pasipanodya JG; Ramachandran G; Hemanth Kumar AK; Srivastava S; Deshpande D; Nuermberger E; Gumbo T
Clin Infect Dis; 2016 Nov; 63(suppl 3):S63-S74. PubMed ID: 27742636
[TBL] [Abstract][Full Text] [Related]
2. Suboptimal Antituberculosis Drug Concentrations and Outcomes in Small and HIV-Coinfected Children in India: Recommendations for Dose Modifications.
Guiastrennec B; Ramachandran G; Karlsson MO; Kumar AKH; Bhavani PK; Gangadevi NP; Swaminathan S; Gupta A; Dooley KE; Savic RM
Clin Pharmacol Ther; 2018 Oct; 104(4):733-741. PubMed ID: 29247506
[TBL] [Abstract][Full Text] [Related]
3. Serum drug concentrations predictive of pulmonary tuberculosis outcomes.
Pasipanodya JG; McIlleron H; Burger A; Wash PA; Smith P; Gumbo T
J Infect Dis; 2013 Nov; 208(9):1464-73. PubMed ID: 23901086
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in HIV-infected Indian children.
Mukherjee A; Velpandian T; Singla M; Kanhiya K; Kabra SK; Lodha R
Int J Tuberc Lung Dis; 2016 May; 20(5):666-72. PubMed ID: 27084822
[TBL] [Abstract][Full Text] [Related]
5. Artificial intelligence-derived 3-Way Concentration-dependent Antagonism of Gatifloxacin, Pyrazinamide, and Rifampicin During Treatment of Pulmonary Tuberculosis.
Pasipanodya JG; Smythe W; Merle CS; Olliaro PL; Deshpande D; Magombedze G; McIlleron H; Gumbo T
Clin Infect Dis; 2018 Nov; 67(suppl_3):S284-S292. PubMed ID: 30496458
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of first-line antituberculosis drugs in HIV-infected children with tuberculosis treated with intermittent regimens in India.
Ramachandran G; Kumar AK; Bhavani PK; Kannan T; Kumar SR; Gangadevi NP; Banurekha VV; Sekar L; Ravichandran N; Mathevan G; Sanjeeva GN; Dayal R; Swaminathan S
Antimicrob Agents Chemother; 2015 Feb; 59(2):1162-7. PubMed ID: 25487804
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic study of isoniazid and pyrazinamide in children: impact of age and nutritional status.
Dayal R; Singh Y; Agarwal D; Kumar M; Swaminathan S; Ramachandran G; Kumar S; Narayan S; Goyal A; Kumar AKH
Arch Dis Child; 2018 Dec; 103(12):1150-1154. PubMed ID: 29514812
[TBL] [Abstract][Full Text] [Related]
8. Low Serum Concentrations of Rifampicin and Pyrazinamide Associated with Poor Treatment Outcomes in Children with Tuberculosis Related to HIV Status.
Ramachandran G; Kumar AK; Kannan T; Bhavani PK; Kumar SR; Gangadevi NP; Banurekha VV; Sudha V; Venkatesh S; Ravichandran N; Kalpana S; Mathevan G; Sanjeeva GN; Agarwal D; Swaminathan S
Pediatr Infect Dis J; 2016 May; 35(5):530-4. PubMed ID: 26825153
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of First-Line Antituberculosis Drugs Using WHO Revised Dosage in Children With Tuberculosis With and Without HIV Coinfection.
Kwara A; Enimil A; Gillani FS; Yang H; Sarfo AM; Dompreh A; Ortsin A; Osei-Tutu L; Kwarteng Owusu S; Wiesner L; Norman J; Kurpewski J; Peloquin CA; Ansong D; Antwi S
J Pediatric Infect Dis Soc; 2016 Dec; 5(4):356-365. PubMed ID: 26407268
[TBL] [Abstract][Full Text] [Related]
10. Age, nutritional status and INH acetylator status affect pharmacokinetics of anti-tuberculosis drugs in children.
Ramachandran G; Hemanth Kumar AK; Bhavani PK; Poorana Gangadevi N; Sekar L; Vijayasekaran D; Banu Rekha VV; Ramesh Kumar S; Ravichandran N; Mathevan G; Swaminathan S
Int J Tuberc Lung Dis; 2013 Jun; 17(6):800-6. PubMed ID: 23676165
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Adequacy of the 2010 Revised World Health Organization Recommended Dosages of the First-line Antituberculosis Drugs for Children: Adequacy of Revised Dosages of TB Drugs for Children.
Yang H; Enimil A; Gillani FS; Antwi S; Dompreh A; Ortsin A; Adu Awhireng E; Owusu M; Wiesner L; Peloquin CA; Kwara A
Pediatr Infect Dis J; 2018 Jan; 37(1):43-51. PubMed ID: 28719501
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic drug monitoring in the treatment of tuberculosis.
Peloquin CA
Drugs; 2002; 62(15):2169-83. PubMed ID: 12381217
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of dried blood spot sampling for pharmacokinetic research and therapeutic drug monitoring of anti-tuberculosis drugs in children.
Martial LC; Kerkhoff J; Martinez N; Rodríguez M; Coronel R; Molinas G; Roman M; Gomez R; Aguirre S; Jongedijk E; Huisman J; Touw DJ; Pérez D; Chaparro G; Gonzalez F; Aarnoutse RE; Alffenaar JW; Magis-Escurra C
Int J Antimicrob Agents; 2018 Jul; 52(1):109-113. PubMed ID: 29751121
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of anti-tuberculosis drugs in Venezuelan children younger than 16 years of age: supportive evidence for the implementation of revised WHO dosing recommendations.
Verhagen LM; López D; Hermans PW; Warris A; de Groot R; García JF; de Waard JH; Aarnoutse RE
Trop Med Int Health; 2012 Dec; 17(12):1449-56. PubMed ID: 23094704
[TBL] [Abstract][Full Text] [Related]
15. Survival and predictors of mortality among children co-infected with tuberculosis and human immunodeficiency virus at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. A retrospective follow-up study.
Atalell KA; Birhan Tebeje N; Ekubagewargies DT
PLoS One; 2018; 13(5):e0197145. PubMed ID: 29787596
[TBL] [Abstract][Full Text] [Related]
16. Determinants of rifampin, isoniazid, pyrazinamide, and ethambutol pharmacokinetics in a cohort of tuberculosis patients.
McIlleron H; Wash P; Burger A; Norman J; Folb PI; Smith P
Antimicrob Agents Chemother; 2006 Apr; 50(4):1170-7. PubMed ID: 16569826
[TBL] [Abstract][Full Text] [Related]
17. Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society.
Monaldi Arch Chest Dis; 1994 Sep; 49(4):327-45. PubMed ID: 8000420
[TBL] [Abstract][Full Text] [Related]
18. Burden of disease and risk factors for death among children treated for tuberculosis in Malawi.
Flick RJ; Kim MH; Simon K; Munthali A; Hosseinipour MC; Rosenberg NE; Kazembe PN; Mpunga J; Ahmed S
Int J Tuberc Lung Dis; 2016 Aug; 20(8):1046-54. PubMed ID: 27393538
[TBL] [Abstract][Full Text] [Related]
19. Tuberculosis in neonates and infants: epidemiology, pathogenesis, clinical manifestations, diagnosis, and management issues.
Skevaki CL; Kafetzis DA
Paediatr Drugs; 2005; 7(4):219-34. PubMed ID: 16117559
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy.
Boulle A; Van Cutsem G; Cohen K; Hilderbrand K; Mathee S; Abrahams M; Goemaere E; Coetzee D; Maartens G
JAMA; 2008 Aug; 300(5):530-9. PubMed ID: 18677025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]